symptoms like pain, stiffness, swelling for more than 1 weeks, you should consider seeing your doctor and getting a diagnosis. Remember that there are more than 100 types of arthritis. It is important to get the specific diagnosis for the type of arthritis you have.
Take your medication the right way. Don't stop taking your medication just because you feel it is not working. Check with your doctor first. You need to understand that it may take several days to several months for a medication to become effective.
Look out for new options. Recently FDA has approved some new drugs for osteoarthritis, rheumatoid arthritis and other arthritis diseases. If feel that the current medication doesn't work well, check with your doctor about possible new options.
Keep educating yourself. It is important to learn something new about arthritis. Find some good websites online and subscribe to their newsletter if they have it. Join one of two active online arthritis communities like forums or bulletin board. Never hesitate to see your doctors and ask questions.
Article Source: www.bestarthritiscare.com
Written By: Nicholas Ahern

Medication fears lead to worse side effects - Vancouver Sun
NEW YORK - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them. The study involved patients with a particular kind of arthritis. While more ...
Roche, Biogen Suspend Arthritis Drug Program After Patient Deaths - Daily Finance
An independent safety monitoring board recommended the pharmaceutical firms halt the program after concluding that the safety risks outweighed the benefits observed in some patients. Specifically, the board detected "serious and opportunistic ...
UPDATE 2-Roche suspends arthritis treatment after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S.-listed Biogen Idec ( BIIB.O ) are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug's future. Roche and ...
UPDATE 4-Roche, Biogen suspends arthritis drug after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S. biotechnology company Biogen Idec ( BIIB.O ) are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting ...
Roche, Biogen Idec Suspend Tests for Arthritis Drug (Update3) - BusinessWeek
March 8 (Bloomberg) -- Roche Holding AG and Biogen Idec Inc. are suspending development of the ocrelizumab treatment for use in arthritis after an independent monitoring board said safety risks outweigh benefits observed in these patients. The ...
Roche, Biogen suffer setback with rheumatoid arthritis drug - Marketwatch
ZURICH (MarketWatch) -- Roche Holding AG (ROG.VX) and Biogen Idec Inc (NASDAQ:BIIB) said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market ...
Major Pharmaceutical Company Stops Arthritis Study After Deaths - FOX News
Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. Roche said the drug, ocrelizumab, was developed together with Biogen ...